BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mitragotri S. Immunization without needles. Nat Rev Immunol 2005;5:905-16. [PMID: 16239901 DOI: 10.1038/nri1728] [Cited by in Crossref: 256] [Cited by in F6Publishing: 232] [Article Influence: 16.0] [Reference Citation Analysis]
Number Citing Articles
1 Raphael AP, Prow TW, Crichton ML, Chen X, Fernando GJP, Kendall MAF. Targeted, Needle-Free Vaccinations in Skin using Multilayered, Densely-Packed Dissolving Microprojection Arrays. Small 2010;6:1785-93. [DOI: 10.1002/smll.201000326] [Cited by in Crossref: 108] [Cited by in F6Publishing: 93] [Article Influence: 9.0] [Reference Citation Analysis]
2 Stano A, van der Vlies AJ, Martino MM, Swartz MA, Hubbell JA, Simeoni E. PPS nanoparticles as versatile delivery system to induce systemic and broad mucosal immunity after intranasal administration. Vaccine 2011;29:804-12. [PMID: 21094269 DOI: 10.1016/j.vaccine.2010.11.010] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 4.3] [Reference Citation Analysis]
3 Park J, Allen MG, Prausnitz MR. Polymer Microneedles for Controlled-Release Drug Delivery. Pharm Res 2006;23:1008-19. [DOI: 10.1007/s11095-006-0028-9] [Cited by in Crossref: 294] [Cited by in F6Publishing: 231] [Article Influence: 18.4] [Reference Citation Analysis]
4 Karande P, Arora A, Pham TK, Stevens D, Wojicki A, Mitragotri S. Transcutaneous immunization using common chemicals. J Control Release 2009;138:134-40. [PMID: 19426770 DOI: 10.1016/j.jconrel.2009.05.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
5 Kim YC, Quan FS, Yoo DG, Compans RW, Kang SM, Prausnitz MR. Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles. J Infect Dis 2010;201:190-8. [PMID: 20017632 DOI: 10.1086/649228] [Cited by in Crossref: 90] [Cited by in F6Publishing: 80] [Article Influence: 7.5] [Reference Citation Analysis]
6 Rane YS, Marston JO. Computational study of fluid flow in tapered orifices for needle-free injectors. Journal of Controlled Release 2020;319:382-96. [DOI: 10.1016/j.jconrel.2020.01.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Veysset D, Lee J, Hassani M, Kooi SE, Thomas EL, Nelson KA. High-velocity micro-projectile impact testing. Applied Physics Reviews 2021;8:011319. [DOI: 10.1063/5.0040772] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
8 Amorij JP, Hinrichs WLj, Frijlink HW, Wilschut JC, Huckriede A. Needle-free influenza vaccination. Lancet Infect Dis 2010;10:699-711. [PMID: 20883966 DOI: 10.1016/S1473-3099(10)70157-2] [Cited by in Crossref: 85] [Cited by in F6Publishing: 32] [Article Influence: 7.1] [Reference Citation Analysis]
9 Kitaoka M, Imamura K, Hirakawa Y, Tahara Y, Kamiya N, Goto M. Needle-free immunization using a solid-in-oil nanodispersion enhanced by a skin-permeable oligoarginine peptide. International Journal of Pharmaceutics 2013;458:334-9. [DOI: 10.1016/j.ijpharm.2013.10.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
10 Wang R, Bian Q, Xu Y, Xu D, Gao J. Recent advances in mechanical force-assisted transdermal delivery of macromolecular drugs. Int J Pharm 2021;602:120598. [PMID: 33862129 DOI: 10.1016/j.ijpharm.2021.120598] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Su X, Kim BS, Kim SR, Hammond PT, Irvine DJ. Layer-by-layer-assembled multilayer films for transcutaneous drug and vaccine delivery. ACS Nano 2009;3:3719-29. [PMID: 19824655 DOI: 10.1021/nn900928u] [Cited by in Crossref: 128] [Cited by in F6Publishing: 109] [Article Influence: 10.7] [Reference Citation Analysis]
12 Imoto J, Ishikawa T, Yamanaka A, Konishi M, Murakami K, Shibahara T, Kubo M, Lim CK, Hamano M, Takasaki T, Kurane I, Udagawa H, Mukuta Y, Konishi E. Needle-free jet injection of small doses of Japanese encephalitis DNA and inactivated vaccine mixture induces neutralizing antibodies in miniature pigs and protects against fetal death and mummification in pregnant sows. Vaccine 2010;28:7373-80. [PMID: 20851083 DOI: 10.1016/j.vaccine.2010.09.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
13 Rodgers AM, Cordeiro AS, Kissenpfennig A, Donnelly RF. Microneedle arrays for vaccine delivery: the possibilities, challenges and use of nanoparticles as a combinatorial approach for enhanced vaccine immunogenicity. Expert Opin Drug Deliv 2018;15:851-67. [PMID: 30051726 DOI: 10.1080/17425247.2018.1505860] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
14 Petersen LK, Huntimer L, Walz K, Ramer-Tait A, Wannemuehler MJ, Narasimhan B. Combinatorial evaluation of in vivo distribution of polyanhydride particle-based platforms for vaccine delivery. Int J Nanomedicine 2013;8:2213-25. [PMID: 23818778 DOI: 10.2147/IJN.S45317] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
15 Kis EE, Winter G, Myschik J. Devices for intradermal vaccination. Vaccine 2012;30:523-38. [DOI: 10.1016/j.vaccine.2011.11.020] [Cited by in Crossref: 67] [Cited by in F6Publishing: 55] [Article Influence: 6.7] [Reference Citation Analysis]
16 Lee W, Pan T, Wang P, Zhuo R, Huang C, Fang J. Erbium:YAG laser enhances transdermal peptide delivery and skin vaccination. Journal of Controlled Release 2008;128:200-8. [DOI: 10.1016/j.jconrel.2008.03.003] [Cited by in Crossref: 65] [Cited by in F6Publishing: 54] [Article Influence: 4.6] [Reference Citation Analysis]
17 Legrand G, Guiguet-Auclair C, Viennet H, Aumeran C, Reynaud D, Badrikian L, Debost-Legrand A. Nurses' practices in the preparation and administration of intramuscular injections in mental health: A cross-sectional study. J Clin Nurs 2019;28:3310-7. [PMID: 31070824 DOI: 10.1111/jocn.14909] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
18 Crommelin DJA. Formulation of Biotech Products, Including Biopharmaceutical Considerations. In: Crommelin DJA, Sindelar RD, Meibohm B, editors. Pharmaceutical Biotechnology. New York: Springer; 2013. pp. 69-99. [DOI: 10.1007/978-1-4614-6486-0_4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
19 Nabi H, Rashid I, Ahmad N, Durrani A, Akbar H, Islam S, Bajwa AA, Shehzad W, Ashraf K, Imran N. Induction of specific humoral immune response in mice immunized with ROP18 nanospheres from Toxoplasma gondii. Parasitol Res 2017;116:359-70. [DOI: 10.1007/s00436-016-5298-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
20 Shima F, Uto T, Akagi T, Baba M, Akashi M. Size effect of amphiphilic poly(γ-glutamic acid) nanoparticles on cellular uptake and maturation of dendritic cells in vivo. Acta Biomater 2013;9:8894-901. [PMID: 23770225 DOI: 10.1016/j.actbio.2013.06.010] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
21 Rath B, Linder T, Cornblath D, Hudson M, Fernandopulle R, Hartmann K, Heininger U, Izurieta H, Killion L, Kokotis P, Oleske J, Vajdy M, Wong V. “All that palsies is not Bell's [1]”—The need to define Bell's palsy as an adverse event following immunization. Vaccine 2007;26:1-14. [DOI: 10.1016/j.vaccine.2007.10.043] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
22 Rohilla P, Marston JO. In-vitro studies of jet injections. International Journal of Pharmaceutics 2019;568:118503. [DOI: 10.1016/j.ijpharm.2019.118503] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
23 Golovkin M, Spitsin S, Andrianov V, Smirnov Y, Xiao Y, Pogrebnyak N, Markley K, Brodzik R, Gleba Y, Isaacs SN, Koprowski H. Smallpox subunit vaccine produced in Planta confers protection in mice. Proc Natl Acad Sci U S A 2007;104:6864-9. [PMID: 17428917 DOI: 10.1073/pnas.0701451104] [Cited by in Crossref: 54] [Cited by in F6Publishing: 43] [Article Influence: 3.6] [Reference Citation Analysis]
24 Joshi N, Duhan V, Lingwal N, Bhaskar S, Upadhyay P. Adjuvant properties of thermal component of hyperthermia enhanced transdermal immunization: effect on dendritic cells. PLoS One 2012;7:e32067. [PMID: 22363798 DOI: 10.1371/journal.pone.0032067] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
25 Diogo GR, Reljic R. Development of a new tuberculosis vaccine: is there value in the mucosal approach? Immunotherapy 2014;6:1001-13. [DOI: 10.2217/imt.14.62] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
26 Simon L, Kim KS, Kanneganti K. Effects of epidermal turnover on the dynamics of percutaneous drug absorption. Mathematical Biosciences 2011;229:16-21. [DOI: 10.1016/j.mbs.2010.10.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
27 Bucarey SA, Pujol M, Poblete J, Nuñez I, Tapia CV, Neira-Carrillo A, Martinez J, Bassa O. Chitosan microparticles loaded with yeast-derived PCV2 virus-like particles elicit antigen-specific cellular immune response in mice after oral administration. Virol J 2014;11:149. [PMID: 25141864 DOI: 10.1186/1743-422X-11-149] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Stadler J, Naderer L, Beffort L, Ritzmann M, Emrich D, Hermanns W, Fiebig K, Saalmüller A, Gerner W, Glatthaar-Saalmüller B, Ladinig A. Safety and immune responses after intradermal application of Porcilis PRRS in either the neck or the perianal region. PLoS One 2018;13:e0203560. [PMID: 30192831 DOI: 10.1371/journal.pone.0203560] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
29 Yeh CY, Yeh TH, Jung CJ, Chen PL, Lien HT, Chia JS. Activated human nasal epithelial cells modulate specific antibody response against bacterial or viral antigens. PLoS One 2013;8:e55472. [PMID: 23405156 DOI: 10.1371/journal.pone.0055472] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
30 Inic-Kanada A, Stojanovic M, Schlacher S, Stein E, Belij-Rammerstorfer S, Marinkovic E, Lukic I, Montanaro J, Schuerer N, Bintner N, Kovacevic-Jovanovic V, Krnjaja O, Mayr UB, Lubitz W, Barisani-Asenbauer T. Delivery of a Chlamydial Adhesin N-PmpC Subunit Vaccine to the Ocular Mucosa Using Particulate Carriers. PLoS One 2015;10:e0144380. [PMID: 26656797 DOI: 10.1371/journal.pone.0144380] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
31 Upadhyay P. Enhanced transdermal-immunization with diptheria-toxoid using local hyperthermia. Vaccine 2006;24:5593-8. [DOI: 10.1016/j.vaccine.2006.04.039] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
32 Heib V, Becker M, Warger T, Rechtsteiner G, Tertilt C, Klein M, Bopp T, Taube C, Schild H, Schmitt E, Stassen M. Mast cells are crucial for early inflammation, migration of Langerhans cells, and CTL responses following topical application of TLR7 ligand in mice. Blood 2007;110:946-53. [DOI: 10.1182/blood-2006-07-036889] [Cited by in Crossref: 77] [Cited by in F6Publishing: 76] [Article Influence: 5.1] [Reference Citation Analysis]
33 Stano A, Nembrini C, Swartz MA, Hubbell JA, Simeoni E. Nanoparticle size influences the magnitude and quality of mucosal immune responses after intranasal immunization. Vaccine 2012;30:7541-6. [PMID: 23103199 DOI: 10.1016/j.vaccine.2012.10.050] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 5.4] [Reference Citation Analysis]
34 Mohizin A, Kim JK. Current engineering and clinical aspects of needle-free injectors: A review. J Mech Sci Technol 2018;32:5737-47. [DOI: 10.1007/s12206-018-1121-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
35 Corbett HJ, Fernando GJ, Chen X, Frazer IH, Kendall MA. Skin vaccination against cervical cancer associated human papillomavirus with a novel micro-projection array in a mouse model. PLoS One 2010;5:e13460. [PMID: 20976136 DOI: 10.1371/journal.pone.0013460] [Cited by in Crossref: 82] [Cited by in F6Publishing: 70] [Article Influence: 6.8] [Reference Citation Analysis]
36 Ruan S, Huang Y, He M, Gao H. Advanced Biomaterials for Cell‐Specific Modulation and Restore of Cancer Immunotherapy. Advanced Science. [DOI: 10.1002/advs.202200027] [Reference Citation Analysis]
37 Qin M, Du G, Sun X. Recent Advances in the Noninvasive Delivery of mRNA. Acc Chem Res 2021. [PMID: 34756014 DOI: 10.1021/acs.accounts.1c00493] [Reference Citation Analysis]
38 Patel GB, Zhou H, Ponce A, Harris G, Chen W. Intranasal immunization with an archaeal lipid mucosal vaccine adjuvant and delivery formulation protects against a respiratory pathogen challenge. PLoS One 2010;5:e15574. [PMID: 21206916 DOI: 10.1371/journal.pone.0015574] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
39 Shin CI, Jeong SD, Rejinold NS, Kim YC. Microneedles for vaccine delivery: challenges and future perspectives. Ther Deliv 2017;8:447-60. [PMID: 28530151 DOI: 10.4155/tde-2017-0032] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 8.8] [Reference Citation Analysis]
40 Pasquevich KA, Estein SM, García Samartino C, Zwerdling A, Coria LM, Barrionuevo P, Fossati CA, Giambartolomei GH, Cassataro J. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection. Infect Immun 2009;77:436-45. [PMID: 18981242 DOI: 10.1128/IAI.01151-08] [Cited by in Crossref: 99] [Cited by in F6Publishing: 43] [Article Influence: 7.1] [Reference Citation Analysis]
41 Su R, Fan W, Yu Q, Dong X, Qi J, Zhu Q, Zhao W, Wu W, Chen Z, Li Y, Lu Y. Size-dependent penetration of nanoemulsions into epidermis and hair follicles: implications for transdermal delivery and immunization. Oncotarget 2017;8:38214-26. [PMID: 28465469 DOI: 10.18632/oncotarget.17130] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 12.8] [Reference Citation Analysis]
42 Le Poole IC, Mehrotra S. Replenishing Regulatory T Cells to Halt Depigmentation in Vitiligo. J Investig Dermatol Symp Proc 2017;18:S38-45. [PMID: 28941492 DOI: 10.1016/j.jisp.2016.10.023] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
43 Pang Q, Ji Y, Li Y, Bermúdez-Humarán LG, Hu G, Zeng Y. Intragastric administration with recombinant Lactococcus lactis producing heme oxygenase-1 prevents lipopolysaccharide-induced endotoxemia in rats. FEMS Microbiol Lett 2008;283:62-8. [PMID: 18422629 DOI: 10.1111/j.1574-6968.2008.01141.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
44 Baleeiro RB, Wiesmüller KH, Reiter Y, Baude B, Dähne L, Patzelt A, Lademann J, Barbuto JA, Walden P. Topical vaccination with functionalized particles targeting dendritic cells. J Invest Dermatol 2013;133:1933-41. [PMID: 23426134 DOI: 10.1038/jid.2013.79] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
45 Kanojia G, Have RT, Soema PC, Frijlink H, Amorij JP, Kersten G. Developments in the formulation and delivery of spray dried vaccines. Hum Vaccin Immunother 2017;13:2364-78. [PMID: 28925794 DOI: 10.1080/21645515.2017.1356952] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
46 Badell E, Nicolle F, Clark S, Majlessi L, Boudou F, Martino A, Castello-Branco L, Leclerc C, Lewis DJ, Marsh PD, Gicquel B, Winter N. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells. Vaccine 2009;27:28-37. [PMID: 18977269 DOI: 10.1016/j.vaccine.2008.10.034] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
47 Lee JA, Jung BG, Kim TH, Kim YM, Park MH, Hyun PM, Jeon JW, Park JK, Cho CW, Suh GH, Lee BJ. Poly D,L-lactide-co-glycolide (PLGA) nanoparticle-encapsulated honeybee (Apis melifera) venom promotes clearance of Salmonella enterica serovar Typhimurium infection in experimentally challenged pigs through the up-regulation of T helper type 1 specific immune responses. Vet Immunol Immunopathol 2014;161:193-204. [PMID: 25193467 DOI: 10.1016/j.vetimm.2014.08.010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
48 Costa RR, Alatorre-meda M, Mano JF. Drug nano-reservoirs synthesized using layer-by-layer technologies. Biotechnology Advances 2015;33:1310-26. [DOI: 10.1016/j.biotechadv.2015.04.005] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 8.0] [Reference Citation Analysis]
49 Shakya AK, Chowdhury MYE, Tao W, Gill HS. Mucosal vaccine delivery: Current state and a pediatric perspective. J Control Release 2016;240:394-413. [PMID: 26860287 DOI: 10.1016/j.jconrel.2016.02.014] [Cited by in Crossref: 67] [Cited by in F6Publishing: 60] [Article Influence: 11.2] [Reference Citation Analysis]
50 Wynaden D, Tohotoa J, Al Omari O, Happell B, Heslop K, Barr L, Sourinathan V. Administering intramuscular injections: how does research translate into practice over time in the mental health setting? Nurse Educ Today 2015;35:620-4. [PMID: 25596035 DOI: 10.1016/j.nedt.2014.12.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
51 Camacho AI, Irache JM, Gamazo C. Recent progress towards development of a Shigella vaccine. Expert Rev Vaccines 2013;12:43-55. [PMID: 23256738 DOI: 10.1586/erv.12.135] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
52 Choi SO, Kim YC, Park JH, Hutcheson J, Gill HS, Yoon YK, Prausnitz MR, Allen MG. An electrically active microneedle array for electroporation. Biomed Microdevices 2010;12:263-73. [PMID: 20012696 DOI: 10.1007/s10544-009-9381-x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 60] [Article Influence: 6.0] [Reference Citation Analysis]
53 Miquel-Clopés A, Bentley EG, Stewart JP, Carding SR. Mucosal vaccines and technology. Clin Exp Immunol 2019;196:205-14. [PMID: 30963541 DOI: 10.1111/cei.13285] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 9.0] [Reference Citation Analysis]
54 Engert J, Anamur C, Engelke L, Fellner C, Lell P, Henke S, Stadler J, Zöls S, Ritzmann M, Winter G. A pilot study using a novel pyrotechnically driven prototype applicator for epidermal powder immunization in piglets. International Journal of Pharmaceutics 2018;545:215-28. [DOI: 10.1016/j.ijpharm.2018.04.039] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
55 McKeage JW, Ruddy BP, Nielsen PMF, Taberner AJ. The effect of jet speed on large volume jet injection. J Control Release 2018;280:51-7. [PMID: 29723614 DOI: 10.1016/j.jconrel.2018.04.054] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 6.5] [Reference Citation Analysis]
56 Tahara Y, Namatsu K, Kamiya N, Hagimori M, Kamiya S, Arakawa M, Goto M. Transcutaneous immunization by a solid-in-oil nanodispersion. Chem Commun (Camb) 2010;46:9200-2. [PMID: 21031190 DOI: 10.1039/c0cc03600e] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
57 Portaro R, Sadek J, Xu H, Ng HD. Controlled Release Using Gas Detonation in Needle-Free Liquid Jet Injections for Drug Delivery. Applied Sciences 2019;9:2712. [DOI: 10.3390/app9132712] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
58 Kim YC, Quan FS, Compans RW, Kang SM, Prausnitz MR. Stability kinetics of influenza vaccine coated onto microneedles during drying and storage. Pharm Res 2011;28:135-44. [PMID: 20387097 DOI: 10.1007/s11095-010-0134-6] [Cited by in Crossref: 70] [Cited by in F6Publishing: 64] [Article Influence: 5.8] [Reference Citation Analysis]
59 Hiraishi Y, Nandakumar S, Choi SO, Lee JW, Kim YC, Posey JE, Sable SB, Prausnitz MR. Bacillus Calmette-Guérin vaccination using a microneedle patch. Vaccine 2011;29:2626-36. [PMID: 21277407 DOI: 10.1016/j.vaccine.2011.01.042] [Cited by in Crossref: 71] [Cited by in F6Publishing: 56] [Article Influence: 6.5] [Reference Citation Analysis]
60 Heida R, Hinrichs WL, Frijlink HW. Inhaled vaccine delivery in the combat against respiratory viruses: a 2021 overview of recent developments and implications for COVID-19. Expert Rev Vaccines 2021;:1-18. [PMID: 33749491 DOI: 10.1080/14760584.2021.1903878] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
61 Jagadeesh G, Prakash GD, Rakesh SG, Allam US, Krishna MG, Eswarappa SM, Chakravortty D. Needleless vaccine delivery using micro-shock waves. Clin Vaccine Immunol 2011;18:539-45. [PMID: 21307276 DOI: 10.1128/CVI.00494-10] [Cited by in Crossref: 38] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
62 Grunwald T, Ulbert S. Improvement of DNA vaccination by adjuvants and sophisticated delivery devices: vaccine-platforms for the battle against infectious diseases. Clin Exp Vaccine Res 2015;4:1-10. [PMID: 25648133 DOI: 10.7774/cevr.2015.4.1.1] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 7.1] [Reference Citation Analysis]
63 Kelly K, Loskutov A, Zehrung D, Puaa K, Labarre P, Muller N, Guiqiang W, Ding H, Hu D, Blackwelder WC. Preventing contamination between injections with multiple-use nozzle needle-free injectors: A safety trial. Vaccine 2008;26:1344-52. [DOI: 10.1016/j.vaccine.2007.12.041] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
64 Zhu Q, Zarnitsyn VG, Ye L, Wen Z, Gao Y, Pan L, Skountzou I, Gill HS, Prausnitz MR, Yang C, Compans RW. Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge. Proc Natl Acad Sci U S A 2009;106:7968-73. [PMID: 19416832 DOI: 10.1073/pnas.0812652106] [Cited by in Crossref: 151] [Cited by in F6Publishing: 132] [Article Influence: 11.6] [Reference Citation Analysis]
65 Pegoraro C, MacNeil S, Battaglia G. Transdermal drug delivery: from micro to nano. Nanoscale 2012;4:1881-94. [PMID: 22334401 DOI: 10.1039/c2nr11606e] [Cited by in Crossref: 82] [Cited by in F6Publishing: 69] [Article Influence: 8.2] [Reference Citation Analysis]
66 Gianchecchi E, Manenti A, Kistner O, Trombetta C, Manini I, Montomoli E. How to assess the effectiveness of nasal influenza vaccines? Role and measurement of sIgA in mucosal secretions. Influenza Other Respir Viruses 2019;13:429-37. [PMID: 31225704 DOI: 10.1111/irv.12664] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
67 Crommelin DJA, Mastrobattista E, Hawe A, Hoogendoorn KH, Jiskoot W. Shifting Paradigms Revisited: Biotechnology and the Pharmaceutical Sciences. J Pharm Sci 2020;109:30-43. [PMID: 31449815 DOI: 10.1016/j.xphs.2019.08.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
68 Denman S, Tellam R, Vuocolo T, Ingham A, Wijffels G, James P, Colditz I, Jacob R. Fleece rot and dermatophilosis (lumpy wool) in sheep: opportunities and challenges for new vaccines. Anim Prod Sci 2022;62:301-20. [DOI: 10.1071/an21120] [Reference Citation Analysis]
69 Islam MA, Firdous J, Choi YJ, Yun CH, Cho CS. Design and application of chitosan microspheres as oral and nasal vaccine carriers: an updated review. Int J Nanomedicine 2012;7:6077-93. [PMID: 23271909 DOI: 10.2147/IJN.S38330] [Cited by in Crossref: 12] [Cited by in F6Publishing: 25] [Article Influence: 1.2] [Reference Citation Analysis]
70 Chen K, Zhou H, Li J, Cheng GJ. A Model on Liquid Penetration Into Soft Material With Application to Needle-Free Jet Injection. Journal of Biomechanical Engineering 2010;132:101005. [DOI: 10.1115/1.4002487] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
71 Song JM, Kim YC, Lipatov AS, Pearton M, Davis CT, Yoo DG, Park KM, Chen LM, Quan FS, Birchall JC, Donis RO, Prausnitz MR, Compans RW, Kang SM. Microneedle delivery of H5N1 influenza virus-like particles to the skin induces long-lasting B- and T-cell responses in mice. Clin Vaccine Immunol 2010;17:1381-9. [PMID: 20631330 DOI: 10.1128/CVI.00100-10] [Cited by in Crossref: 57] [Cited by in F6Publishing: 33] [Article Influence: 4.8] [Reference Citation Analysis]
72 Park, K. Dry coating of immunotherapeutics to densely packed and short microprojection arrays. Journal of Controlled Release 2009;139:171. [DOI: 10.1016/j.jconrel.2009.09.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
73 Longet S, Lundahl MLE, Lavelle EC. Targeted Strategies for Mucosal Vaccination. Bioconjugate Chem 2018;29:613-23. [DOI: 10.1021/acs.bioconjchem.7b00738] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
74 Pogrebnyak N, Markley K, Smirnov Y, Brodzik R, Bandurska K, Koprowski H, Golovkin M. Collard and cauliflower as a base for production of recombinant antigens. Plant Science 2006;171:677-85. [DOI: 10.1016/j.plantsci.2006.06.017] [Cited by in Crossref: 7] [Article Influence: 0.4] [Reference Citation Analysis]
75 Weiss R, Hessenberger M, Kitzmüller S, Bach D, Weinberger EE, Krautgartner WD, Hauser-Kronberger C, Malissen B, Boehler C, Kalia YN, Thalhamer J, Scheiblhofer S. Transcutaneous vaccination via laser microporation. J Control Release 2012;162:391-9. [PMID: 22750193 DOI: 10.1016/j.jconrel.2012.06.031] [Cited by in Crossref: 72] [Cited by in F6Publishing: 58] [Article Influence: 7.2] [Reference Citation Analysis]
76 Shin JH, Lee JH, Jeong SD, Noh JY, Lee HW, Song CS, Kim YC. C-di-GMP with influenza vaccine showed enhanced and shifted immune responses in microneedle vaccination in the skin. Drug Deliv Transl Res 2020;10:815-25. [PMID: 32141036 DOI: 10.1007/s13346-020-00728-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
77 Li H, Yu Y, Faraji Dana S, Li B, Lee CY, Kang L. Novel engineered systems for oral, mucosal and transdermal drug delivery. J Drug Target 2013;21:611-29. [PMID: 23869879 DOI: 10.3109/1061186X.2013.805335] [Cited by in Crossref: 31] [Cited by in F6Publishing: 8] [Article Influence: 3.4] [Reference Citation Analysis]
78 Manion JR, Cape SP, Mcadams DH, Rebits LG, Evans S, Sievers RE. Inhalable Antibiotics Manufactured Through Use of Near-Critical or Supercritical Fluids. Aerosol Science and Technology 2012;46:403-10. [DOI: 10.1080/02786826.2011.634453] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
79 Schoppink J, Rivas DF. Jet injectors: Perspectives for small volume delivery with lasers. Advanced Drug Delivery Reviews 2022. [DOI: 10.1016/j.addr.2021.114109] [Reference Citation Analysis]
80 Kim YC, Jarrahian C, Zehrung D, Mitragotri S, Prausnitz MR. Delivery systems for intradermal vaccination. Curr Top Microbiol Immunol 2012;351:77-112. [PMID: 21472533 DOI: 10.1007/82_2011_123] [Cited by in Crossref: 36] [Cited by in F6Publishing: 52] [Article Influence: 3.3] [Reference Citation Analysis]
81 Wang C, Ye Y, Hu Q, Bellotti A, Gu Z. Tailoring Biomaterials for Cancer Immunotherapy: Emerging Trends and Future Outlook. Adv Mater 2017;29:1606036. [DOI: 10.1002/adma.201606036] [Cited by in Crossref: 136] [Cited by in F6Publishing: 128] [Article Influence: 27.2] [Reference Citation Analysis]
82 Ng HI, Fernando GJ, Kendall MA. Induction of potent CD8⁺ T cell responses through the delivery of subunit protein vaccines to skin antigen-presenting cells using densely packed microprojection arrays. J Control Release 2012;162:477-84. [PMID: 22841796 DOI: 10.1016/j.jconrel.2012.07.024] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
83 Chen X, Corbett HJ, Yukiko SR, Raphael AP, Fairmaid EJ, Prow TW, Brown LE, Fernando GJP, Kendall MAF. Site-Selectively Coated, Densely-Packed Microprojection Array Patches for Targeted Delivery of Vaccines to Skin. Adv Funct Mater 2011;21:464-73. [DOI: 10.1002/adfm.201000966] [Cited by in Crossref: 36] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
84 Qiu J, Yang Y, Huang L, Wang L, Jiang Z, Gong J, Wang W, Wang H, Guo S, Li C, Wei S, Mo Z, Xia J. Immunogenicity and safety evaluation of bivalent types 1 and 3 oral poliovirus vaccine by comparing different poliomyelitis vaccination schedules in China: A randomized controlled non-inferiority clinical trial. Hum Vaccin Immunother 2017;13:1-10. [PMID: 28362135 DOI: 10.1080/21645515.2017.1288769] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
85 Veysset D, Hsieh AJ, Kooi S, Maznev AA, Masser KA, Nelson KA. Dynamics of supersonic microparticle impact on elastomers revealed by real-time multi-frame imaging. Sci Rep 2016;6:25577. [PMID: 27156501 DOI: 10.1038/srep25577] [Cited by in Crossref: 44] [Cited by in F6Publishing: 18] [Article Influence: 7.3] [Reference Citation Analysis]
86 Zeng D, Wu N, Qian L, Shi H, Kang Y. Experimental investigation on penetration performance of larger volume needle-free injection device. J Mech Sci Technol 2020;34:3897-909. [DOI: 10.1007/s12206-020-0840-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
87 Daudel D, Weidinger G, Spreng S. Use of attenuated bacteria as delivery vectors for DNA vaccines. Expert Review of Vaccines 2014;6:97-110. [DOI: 10.1586/14760584.6.1.97] [Cited by in Crossref: 45] [Cited by in F6Publishing: 34] [Article Influence: 5.6] [Reference Citation Analysis]
88 Kim M, Kim T, Yoo H, Yang M. Expression and assembly of ApxIIA toxin of Actinobacillus pleuropneumoniae fused with the enterotoxigenic E. coli heat-labile toxin B subunit in transgenic tobacco. Plant Cell Tiss Organ Cult 2011;105:375-82. [DOI: 10.1007/s11240-010-9877-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
89 Kim MY, Kim TG, Yang MS. Production and immunogenicity of Actinobacillus pleuropneumoniae ApxIIA protein in transgenic rice callus. Protein Expr Purif 2017;132:116-23. [PMID: 27215671 DOI: 10.1016/j.pep.2016.05.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
90 Zeng D, Wu N, Qian L, Shi H, Kang Y. A Novel Controllable Pneumatic Needle-Free Injection System for Larger-Volume Drug Delivery. Journal of Pharmaceutical Sciences 2020;109:1772-9. [DOI: 10.1016/j.xphs.2020.02.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
91 Gómez E, Mayorga C, Gómez F, Blázquez AB, Díaz-perales A, Blanca M, Torres MJ. Food allergy: management, diagnosis and treatment strategies. Immunotherapy 2013;5:755-68. [DOI: 10.2217/imt.13.63] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
92 Datey A, Gopalan J, Chakravortty D. Needleless or Noninvasive Delivery Technology. Methods Mol Biol 2021;2183:437-46. [PMID: 32959258 DOI: 10.1007/978-1-0716-0795-4_23] [Reference Citation Analysis]
93 Girard MP. [Vaccines for the future]. Ann Pharm Fr 2009;67:203-12. [PMID: 19446671 DOI: 10.1016/j.pharma.2009.02.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
94 Virdi V, Juarez P, Boudolf V, Depicker A. Recombinant IgA production for mucosal passive immunization, advancing beyond the hurdles. Cell Mol Life Sci 2016;73:535-45. [PMID: 26511868 DOI: 10.1007/s00018-015-2074-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
95 Ko EY, Cho J, Cho JH, Jo K, Lee SH, Chung YJ, Jung S. Reduction in Lesion Incidence in Pork Carcass Using Transdermal Needle-free Injection of Foot-and-Mouth Disease Vaccine. Korean J Food Sci Anim Resour 2018;38:1155-9. [PMID: 30675107 DOI: 10.5851/kosfa.2018.e46] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
96 Amorij JP, Westra TA, Hinrichs WL, Huckriede A, Frijlink HW. Towards an oral influenza vaccine: comparison between intragastric and intracolonic delivery of influenza subunit vaccine in a murine model. Vaccine 2007;26:67-76. [PMID: 18061315 DOI: 10.1016/j.vaccine.2007.10.045] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
97 Makidon PE, Nigavekar SS, Bielinska AU, Mank N, Shetty AM, Suman J, Knowlton J, Myc A, Rook T, Baker JR Jr. Characterization of stability and nasal delivery systems for immunization with nanoemulsion-based vaccines. J Aerosol Med Pulm Drug Deliv 2010;23:77-89. [PMID: 19778268 DOI: 10.1089/jamp.2009.0766] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
98 Hogan NC, Taberner AJ, Jones LA, Hunter IW. Needle-free delivery of macromolecules through the skin using controllable jet injectors. Expert Opin Drug Deliv 2015;12:1637-48. [PMID: 26004884 DOI: 10.1517/17425247.2015.1049531] [Cited by in Crossref: 43] [Cited by in F6Publishing: 24] [Article Influence: 6.1] [Reference Citation Analysis]
99 Howlader DR, Koley H, Maiti S, Bhaumik U, Mukherjee P, Dutta S. A brief review on the immunological scenario and recent developmental status of vaccines against enteric fever. Vaccine 2017;35:6359-66. [DOI: 10.1016/j.vaccine.2017.09.066] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
100 Battula N, Menezes V, Bhalekar S, Bhalekar SH, Nejad SM, Hosseini H. Impulse-powered needle-free syringe for vaccine/drug injection. Technol Health Care 2017;25:1131-8. [PMID: 28946604 DOI: 10.3233/THC-171022] [Reference Citation Analysis]
101 Travis CR. As Plain as the Nose on Your Face: The Case for A Nasal (Mucosal) Route of Vaccine Administration for Covid-19 Disease Prevention. Front Immunol 2020;11:591897. [PMID: 33117404 DOI: 10.3389/fimmu.2020.591897] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
102 Bimczok D, Rau H, Wundrack N, Naumann M, Rothkötter H, Mccullough K, Summerfield A. Cholera toxin promotes the generation of semi-mature porcine monocyte-derived dendritic cells that are unable to stimulate T cells. Vet Res 2007;38:597-612. [DOI: 10.1051/vetres:2007020] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
103 Kim SH, Jang YS. Antigen targeting to M cells for enhancing the efficacy of mucosal vaccines. Exp Mol Med 2014;46:e85. [PMID: 24626171 DOI: 10.1038/emm.2013.165] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 6.5] [Reference Citation Analysis]
104 Tan G, Xu P, Lawson LB, He J, Freytag LC, Clements JD, John VT. Hydration effects on skin microstructure as probed by high-resolution cryo-scanning electron microscopy and mechanistic implications to enhanced transcutaneous delivery of biomacromolecules. J Pharm Sci 2010;99:730-40. [PMID: 19582754 DOI: 10.1002/jps.21863] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 4.7] [Reference Citation Analysis]
105 van den Berg JH, Nujien B, Beijnen JH, Vincent A, van Tinteren H, Kluge J, Woerdeman LA, Hennink WE, Storm G, Schumacher TN, Haanen JB. Optimization of intradermal vaccination by DNA tattooing in human skin. Hum Gene Ther 2009;20:181-9. [PMID: 19301471 DOI: 10.1089/hgt.2008.073] [Cited by in Crossref: 43] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
106 Gozdemir M, Demircioglu RI, Karabayirli S, Sert H, Muslu B, Usta B, Yazici U. A Needle-Free Injection System (INJEX™) with lidocaine for epidural needle insertion: A randomized controlled trial. Pak J Med Sci 2016;32:756-61. [PMID: 27375728 DOI: 10.12669/pjms.323.9174] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
107 Grant TM, Stockwell KD, Morrison JB, Mann DD. Effect of injection pressure and fluid volume and density on the jet dispersion pattern of needle-free injection devices. Biosystems Engineering 2015;138:59-64. [DOI: 10.1016/j.biosystemseng.2015.04.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
108 Taghinezhad-S S, Mohseni AH, Bermúdez-Humarán LG, Casolaro V, Cortes-Perez NG, Keyvani H, Simal-Gandara J. Probiotic-Based Vaccines May Provide Effective Protection against COVID-19 Acute Respiratory Disease. Vaccines (Basel) 2021;9:466. [PMID: 34066443 DOI: 10.3390/vaccines9050466] [Reference Citation Analysis]
109 Ye Y, Yu J, Wen D, Kahkoska AR, Gu Z. Polymeric microneedles for transdermal protein delivery. Adv Drug Deliv Rev 2018;127:106-18. [PMID: 29408182 DOI: 10.1016/j.addr.2018.01.015] [Cited by in Crossref: 137] [Cited by in F6Publishing: 114] [Article Influence: 34.3] [Reference Citation Analysis]
110 Sullivan S, Murthy N, Prausnitz M. Minimally Invasive Protein Delivery with Rapidly Dissolving Polymer Microneedles. Adv Mater 2008;20:933-8. [DOI: 10.1002/adma.200701205] [Cited by in Crossref: 250] [Cited by in F6Publishing: 213] [Article Influence: 17.9] [Reference Citation Analysis]
111 Hossain MK, Ahmed T, Bhusal P, Subedi RK, Salahshoori I, Soltani M, Hassanzadeganroudsari M. Microneedle Systems for Vaccine Delivery: the story so far. Expert Rev Vaccines 2020;19:1153-66. [PMID: 33427523 DOI: 10.1080/14760584.2020.1874928] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
112 Xia Y, Fan Q, Hao D, Wu J, Ma G, Su Z. Chitosan-based mucosal adjuvants: Sunrise on the ocean. Vaccine. 2015;33:5997-6010. [PMID: 26271831 DOI: 10.1016/j.vaccine.2015.07.101] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 6.9] [Reference Citation Analysis]
113 Donadei A, Gallorini S, Berti F, O’hagan DT, Adamo R, Baudner BC. Rational Design of Adjuvant for Skin Delivery: Conjugation of Synthetic β-Glucan Dectin-1 Agonist to Protein Antigen. Mol Pharmaceutics 2015;12:1662-72. [DOI: 10.1021/acs.molpharmaceut.5b00072] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
114 Griffin DE, Pan CH. Measles: old vaccines, new vaccines. Curr Top Microbiol Immunol 2009;330:191-212. [PMID: 19203111 DOI: 10.1007/978-3-540-70617-5_10] [Cited by in Crossref: 17] [Cited by in F6Publishing: 25] [Article Influence: 1.3] [Reference Citation Analysis]
115 Koppang EO, Bjerkås I, Haugarvoll E, Chan EK, Szabo NJ, Ono N, Akikusa B, Jirillo E, Poppe TT, Sveier H, Tørud B, Satoh M. Vaccination-induced systemic autoimmunity in farmed Atlantic salmon. J Immunol 2008;181:4807-14. [PMID: 18802084 DOI: 10.4049/jimmunol.181.7.4807] [Cited by in Crossref: 81] [Cited by in F6Publishing: 64] [Article Influence: 5.8] [Reference Citation Analysis]
116 Patel GB, Chen W. Archaeal lipid mucosal vaccine adjuvant and delivery system. Expert Review of Vaccines 2014;9:431-40. [DOI: 10.1586/erv.10.34] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
117 Araki S, Wakabayashi R, Moniruzzaman M, Kamiya N, Goto M. Ionic liquid-mediated transcutaneous protein delivery with solid-in-oil nanodispersions. Med Chem Commun 2015;6:2124-8. [DOI: 10.1039/c5md00378d] [Cited by in Crossref: 35] [Article Influence: 5.0] [Reference Citation Analysis]
118 Portaro R, Ng HD. Experiments and Modeling of Air-Powered Needle-Free Liquid Injectors. J Med Biol Eng 2015;35:685-95. [DOI: 10.1007/s40846-015-0075-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
119 Himes R, Lee S, Mcmenigall K, Russell-jones G. The influence of molecular adjuvants in the cutaneous response to antigen after topical vaccination. Vaccine 2011;29:5393-8. [DOI: 10.1016/j.vaccine.2011.05.085] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
120 Korkmaz E, Balmert SC, Carey CD, Erdos G, Falo LD Jr. Emerging skin-targeted drug delivery strategies to engineer immunity: A focus on infectious diseases. Expert Opin Drug Deliv 2021;18:151-67. [PMID: 32924651 DOI: 10.1080/17425247.2021.1823964] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
121 Etzl EE, Winter G, Engert J. Toward intradermal vaccination: preparation of powder formulations by collapse freeze-drying. Pharmaceutical Development and Technology 2013;19:213-22. [DOI: 10.3109/10837450.2013.769567] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
122 Kostadinova AI, Willemsen LE, Knippels LM, Garssen J. Immunotherapy - risk/benefit in food allergy. Pediatr Allergy Immunol 2013;24:633-44. [PMID: 24112425 DOI: 10.1111/pai.12122] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
123 Yan Q, Liu H, Cheng Z, Xue Y, Cheng Z, Dai X, Shan W, Chen F. Immunotherapeutic effect of BCG-polysaccharide nucleic acid powder on Mycobacterium tuberculosis-infected mice using microneedle patches. Drug Deliv 2017;24:1648-53. [PMID: 29069980 DOI: 10.1080/10717544.2017.1391892] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
124 Engelke L, Winter G, Hook S, Engert J. Recent insights into cutaneous immunization: How to vaccinate via the skin. Vaccine 2015;33:4663-74. [PMID: 26006087 DOI: 10.1016/j.vaccine.2015.05.012] [Cited by in Crossref: 57] [Cited by in F6Publishing: 53] [Article Influence: 8.1] [Reference Citation Analysis]
125 Korkmaz E, Balmert SC, Sumpter TL, Carey CD, Erdos G, Falo LD Jr. Microarray patches enable the development of skin-targeted vaccines against COVID-19. Adv Drug Deliv Rev 2021;171:164-86. [PMID: 33539853 DOI: 10.1016/j.addr.2021.01.022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
126 Shin JH, Park JK, Lee DH, Quan FS, Song CS, Kim YC. Microneedle Vaccination Elicits Superior Protection and Antibody Response over Intranasal Vaccination against Swine-Origin Influenza A (H1N1) in Mice. PLoS One 2015;10:e0130684. [PMID: 26086590 DOI: 10.1371/journal.pone.0130684] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
127 Weissmueller NT, Marsay L, Schiffter HA, Carlisle RC, Rollier CS, Prud'homme RK, Pollard AJ. Alternative vaccine administration by powder injection: Needle-free dermal delivery of the glycoconjugate meningococcal group Y vaccine. PLoS One 2017;12:e0183427. [PMID: 28837693 DOI: 10.1371/journal.pone.0183427] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
128 Li Y, Li X, Liu H, Zhuang S, Yang J, Zhang F. Intranasal immunization with recombinant Lactococci carrying human papillomavirus E7 protein and mouse interleukin-12 DNA induces E7-specific antitumor effects in C57BL/6 mice. Oncol Lett 2014;7:576-82. [PMID: 24396491 DOI: 10.3892/ol.2013.1743] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
129 Hellfritzsch M, Scherließ R. Mucosal Vaccination via the Respiratory Tract. Pharmaceutics 2019;11:E375. [PMID: 31374959 DOI: 10.3390/pharmaceutics11080375] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
130 Tahara Y, Morita K, Wakabayashi R, Kamiya N, Goto M. Biocompatible Ionic Liquid Enhances Transdermal Antigen Peptide Delivery and Preventive Vaccination Effect. Mol Pharmaceutics 2020;17:3845-56. [DOI: 10.1021/acs.molpharmaceut.0c00598] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 4.5] [Reference Citation Analysis]
131 Mitragotri S. Current status and future prospects of needle-free liquid jet injectors. Nat Rev Drug Discov 2006;5:543-8. [PMID: 16816837 DOI: 10.1038/nrd2076] [Cited by in Crossref: 202] [Cited by in F6Publishing: 146] [Article Influence: 12.6] [Reference Citation Analysis]
132 Suzuki T, Ainai A, Hasegawa H. Functional and structural characteristics of secretory IgA antibodies elicited by mucosal vaccines against influenza virus. Vaccine 2017;35:5297-302. [PMID: 28780981 DOI: 10.1016/j.vaccine.2017.07.093] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
133 Schild S, Nelson EJ, Camilli A. Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice. Infect Immun 2008;76:4554-63. [PMID: 18678672 DOI: 10.1128/IAI.00532-08] [Cited by in Crossref: 119] [Cited by in F6Publishing: 70] [Article Influence: 8.5] [Reference Citation Analysis]
134 Delgado-Charro MB, Guy RH. Effective use of transdermal drug delivery in children. Adv Drug Deliv Rev 2014;73:63-82. [PMID: 24333231 DOI: 10.1016/j.addr.2013.11.014] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 5.3] [Reference Citation Analysis]
135 Brandtzaeg P. Induction of secretory immunity and memory at mucosal surfaces. Vaccine 2007;25:5467-84. [DOI: 10.1016/j.vaccine.2006.12.001] [Cited by in Crossref: 317] [Cited by in F6Publishing: 295] [Article Influence: 21.1] [Reference Citation Analysis]
136 Borges O, Lebre F, Bento D, Borchard G, Junginger HE. Mucosal vaccines: recent progress in understanding the natural barriers. Pharm Res 2010;27:211-23. [PMID: 19953309 DOI: 10.1007/s11095-009-0011-3] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 3.9] [Reference Citation Analysis]
137 Arora A, Prausnitz MR, Mitragotri S. Micro-scale devices for transdermal drug delivery. Int J Pharm 2008;364:227-36. [PMID: 18805472 DOI: 10.1016/j.ijpharm.2008.08.032] [Cited by in Crossref: 285] [Cited by in F6Publishing: 223] [Article Influence: 20.4] [Reference Citation Analysis]
138 Kunda NK, Wafula D, Tram M, Wu TH, Muttil P. A stable live bacterial vaccine. Eur J Pharm Biopharm 2016;103:109-17. [PMID: 27020530 DOI: 10.1016/j.ejpb.2016.03.027] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
139 Dong W, Zhang H, Yin X, Liu Y, Chen D, Liang X, Jin X, Lv J, Ma J, Tang K, Hu Z, Qin X, Huang B. Oral delivery of tumor microparticle vaccines activates NOD2 signaling pathway in ileac epithelium rendering potent antitumor T cell immunity. Oncoimmunology 2017;6:e1282589. [PMID: 28405506 DOI: 10.1080/2162402X.2017.1282589] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
140 Fischer MA, Davies ML, Reider IE, Heipertz EL, Epler MR, Sei JJ, Ingersoll MA, Rooijen NV, Randolph GJ, Norbury CC. CD11b⁺, Ly6G⁺ cells produce type I interferon and exhibit tissue protective properties following peripheral virus infection. PLoS Pathog 2011;7:e1002374. [PMID: 22102816 DOI: 10.1371/journal.ppat.1002374] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 3.4] [Reference Citation Analysis]
141 Hirschberg HJ, van de Wijdeven GG, Kelder AB, van den Dobbelsteen GP, Kersten GF. Bioneedles™ as vaccine carriers. Vaccine 2008;26:2389-97. [DOI: 10.1016/j.vaccine.2008.02.067] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
142 von Moos S, Kündig TM, Senti G. Novel Administration Routes for Allergen-Specific Immunotherapy: A Review of Intralymphatic and Epicutaneous Allergen-Specific Immunotherapy. Immunology and Allergy Clinics of North America 2011;31:391-406. [DOI: 10.1016/j.iac.2011.02.012] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
143 Ebrahimi S, Abbasnia K, Motealleh A, Kooroshfard N, Kamali F, Ghaffarinezhad F. Effect of lidocaine phonophoresis on sensory blockade: pulsed or continuous mode of therapeutic ultrasound? Physiotherapy 2012;98:57-63. [DOI: 10.1016/j.physio.2011.01.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
144 Battula N, Menezes V, Hosseini H. A miniature shock wave driven micro-jet injector for needle-free vaccine/drug delivery: A Miniature Shock Wave Driven Micro-Jet Injector. Biotechnol Bioeng 2016;113:2507-12. [DOI: 10.1002/bit.26016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
145 Moon S, Wang Y, Edens C, Gentsch JR, Prausnitz MR, Jiang B. Dose sparing and enhanced immunogenicity of inactivated rotavirus vaccine administered by skin vaccination using a microneedle patch. Vaccine 2013;31:3396-402. [PMID: 23174199 DOI: 10.1016/j.vaccine.2012.11.027] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 5.9] [Reference Citation Analysis]
146 Zhang Y, Yu J, Kahkoska AR, Wang J, Buse JB, Gu Z. Advances in transdermal insulin delivery. Adv Drug Deliv Rev 2019;139:51-70. [PMID: 30528729 DOI: 10.1016/j.addr.2018.12.006] [Cited by in Crossref: 85] [Cited by in F6Publishing: 65] [Article Influence: 21.3] [Reference Citation Analysis]
147 Cho HJ, Oh YK, Kim YB. Advances in human papilloma virus vaccines: a patent review. Expert Opin Ther Pat 2011;21:295-309. [PMID: 21250872 DOI: 10.1517/13543776.2011.551114] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
148 Rohilla P, Rane YS, Lawal I, Le Blanc A, Davis J, Thomas JB, Weeks C, Tran W, Fisher P, Broderick KE, Simmons JA, Marston JO. Characterization of jets for impulsively-started needle-free jet injectors: Influence of fluid properties. Journal of Drug Delivery Science and Technology 2019;53:101167. [DOI: 10.1016/j.jddst.2019.101167] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 4.7] [Reference Citation Analysis]
149 Gomes KB, D'Souza B, Vijayanand S, Menon I, D'Souza MJ. A Dual-Delivery Platform for Vaccination using Antigen-loaded Nanoparticles in Dissolving Microneedles. Int J Pharm 2021;:121393. [PMID: 34929312 DOI: 10.1016/j.ijpharm.2021.121393] [Reference Citation Analysis]
150 Anamur C, Winter G, Engert J. Stability of collapse lyophilized influenza vaccine formulations. International Journal of Pharmaceutics 2015;483:131-41. [DOI: 10.1016/j.ijpharm.2015.01.053] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
151 Senti G, von Moos S, Kündig TM. Epicutaneous allergen administration: is this the future of allergen-specific immunotherapy? Allergy 2011;66:798-809. [PMID: 21518374 DOI: 10.1111/j.1398-9995.2011.02560.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 4.3] [Reference Citation Analysis]
152 Singh B, Maharjan S, Sindurakar P, Cho KH, Choi YJ, Cho CS. Needle-Free Immunization with Chitosan-Based Systems. Int J Mol Sci 2018;19:E3639. [PMID: 30463211 DOI: 10.3390/ijms19113639] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
153 Inic-Kanada A, Stojanovic M, Marinkovic E, Becker E, Stein E, Lukic I, Djokic R, Schuerer N, Hegemann JH, Barisani-Asenbauer T. A Probiotic Adjuvant Lactobacillus rhamnosus Enhances Specific Immune Responses after Ocular Mucosal Immunization with Chlamydial Polymorphic Membrane Protein C. PLoS One 2016;11:e0157875. [PMID: 27636704 DOI: 10.1371/journal.pone.0157875] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
154 Kim SH, Lee KY, Jang YS. Mucosal Immune System and M Cell-targeting Strategies for Oral Mucosal Vaccination. Immune Netw 2012;12:165-75. [PMID: 23213309 DOI: 10.4110/in.2012.12.5.165] [Cited by in Crossref: 61] [Cited by in F6Publishing: 54] [Article Influence: 6.1] [Reference Citation Analysis]
155 Baxter J, Mitragotri S. Needle-free liquid jet injections: mechanisms and applications. Expert Rev Med Devices 2006;3:565-74. [PMID: 17064242 DOI: 10.1586/17434440.3.5.565] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 3.4] [Reference Citation Analysis]
156 Tagawa Y, Oudalov N, El Ghalbzouri A, Sun C, Lohse D. Needle-free injection into skin and soft matter with highly focused microjets. Lab Chip 2013;13:1357-63. [PMID: 23386257 DOI: 10.1039/c2lc41204g] [Cited by in Crossref: 63] [Cited by in F6Publishing: 39] [Article Influence: 7.0] [Reference Citation Analysis]
157 Propst CN, Nwabueze AO, Kanev IL, Pepin RE, Gutting BW, Morozov VN, van Hoek ML. Nanoaerosols reduce required effective dose of liposomal levofloxacin against pulmonary murine Francisella tularensis subsp. novicida infection. J Nanobiotechnology 2016;14:29. [PMID: 27090889 DOI: 10.1186/s12951-016-0182-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
158 Engelke L, Winter G, Engert J. Application of water-soluble polyvinyl alcohol-based film patches on laser microporated skin facilitates intradermal macromolecule and nanoparticle delivery. European Journal of Pharmaceutics and Biopharmaceutics 2018;128:119-30. [DOI: 10.1016/j.ejpb.2018.04.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
159 Sonzogni AS, Yealland G, Kar M, Wedepohl S, Gugliotta LM, Gonzalez VDG, Hedtrich S, Calderón M, Minari RJ. Effect of Delivery Platforms Structure on the Epidermal Antigen Transport for Topical Vaccination. Biomacromolecules 2018;19:4607-16. [DOI: 10.1021/acs.biomac.8b01307] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
160 Bal SM, Ding Z, van Riet E, Jiskoot W, Bouwstra JA. Advances in transcutaneous vaccine delivery: Do all ways lead to Rome? Journal of Controlled Release 2010;148:266-82. [DOI: 10.1016/j.jconrel.2010.09.018] [Cited by in Crossref: 140] [Cited by in F6Publishing: 127] [Article Influence: 11.7] [Reference Citation Analysis]
161 Weissmueller NT, Schiffter HA, Carlisle RC, Rollier CS, Pollard AJ. Needle-Free Dermal Delivery of a Diphtheria Toxin CRM197 Mutant on Potassium-Doped Hydroxyapatite Microparticles. Clin Vaccine Immunol 2015;22:586-92. [PMID: 25809632 DOI: 10.1128/CVI.00121-15] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
162 Kersten G, Hirschberg H. Needle-free vaccine delivery. Expert Opinion on Drug Delivery 2007;4:459-74. [DOI: 10.1517/17425247.4.5.459] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 3.1] [Reference Citation Analysis]
163 Desai SN, Kamat D. Closing the global immunization gap: delivery of lifesaving vaccines through innovation and technology. Pediatr Rev 2014;35:e32-40. [PMID: 24986933 DOI: 10.1542/pir.35-7-e32] [Cited by in Crossref: 5] [Article Influence: 0.6] [Reference Citation Analysis]
164 Toyoizumi T, Ohta R, Nakagawa Y, Tazura Y, Kuwagata M, Noguchi S, Yamakage K. Use of the in vivo skin comet assay to evaluate the DNA-damaging potential of chemicals applied to the skin. Mutat Res 2011;726:175-80. [PMID: 21944904 DOI: 10.1016/j.mrgentox.2011.09.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
165 Weniger BG, Papania MJ. Alternative vaccine delivery methods. Vaccines. Elsevier; 2013. pp. 1200-31. [DOI: 10.1016/b978-1-4557-0090-5.00063-x] [Cited by in Crossref: 28] [Article Influence: 3.1] [Reference Citation Analysis]
166 Cox L, Compalati E, Kundig T, Larche M. New directions in immunotherapy. Curr Allergy Asthma Rep 2013;13:178-95. [PMID: 23315329 DOI: 10.1007/s11882-012-0335-7] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 4.8] [Reference Citation Analysis]
167 Kitaoka M, Wakabayashi R, Kamiya N, Goto M. Solid-in-oil nanodispersions for transdermal drug delivery systems. Biotechnol J 2016;11:1375-85. [PMID: 27529824 DOI: 10.1002/biot.201600081] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
168 Weniger BG, Papania MJ. Alternative vaccine delivery methods. Vaccines. Elsevier; 2008. pp. 1357-92. [DOI: 10.1016/b978-1-4160-3611-1.50065-9] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
169 Quan FS, Compans RW, Kang SM. Oral vaccination with inactivated influenza vaccine induces cross-protective immunity. Vaccine 2012;30:180-8. [PMID: 22107852 DOI: 10.1016/j.vaccine.2011.11.028] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
170 Shim BS, Stadler K, Nguyen HH, Yun CH, Kim DW, Chang J, Czerkinsky C, Song MK. Sublingual immunization with recombinant adenovirus encoding SARS-CoV spike protein induces systemic and mucosal immunity without redirection of the virus to the brain. Virol J 2012;9:215. [PMID: 22995185 DOI: 10.1186/1743-422X-9-215] [Cited by in Crossref: 32] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
171 Yoh JJ, Jang H, Park M, Han T, Hah J. A bio-ballistic micro-jet for drug injection into animal skin using a Nd:YAG laser. Shock Waves 2016;26:39-43. [DOI: 10.1007/s00193-015-0565-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
172 Oosterhuis K, van den Berg JH, Schumacher TN, Haanen JB. DNA vaccines and intradermal vaccination by DNA tattooing. Curr Top Microbiol Immunol 2012;351:221-50. [PMID: 21107792 DOI: 10.1007/82_2010_117] [Cited by in Crossref: 9] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
173 Lebre F, Borchard G, de Lima MC, Borges O. Progress towards a needle-free hepatitis B vaccine. Pharm Res 2011;28:986-1012. [PMID: 21088986 DOI: 10.1007/s11095-010-0314-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
174 Kim YC, Park JH, Prausnitz MR. Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev 2012;64:1547-68. [PMID: 22575858 DOI: 10.1016/j.addr.2012.04.005] [Cited by in Crossref: 838] [Cited by in F6Publishing: 711] [Article Influence: 83.8] [Reference Citation Analysis]
175 Sullivan SP, Koutsonanos DG, Del Pilar Martin M, Lee JW, Zarnitsyn V, Choi SO, Murthy N, Compans RW, Skountzou I, Prausnitz MR. Dissolving polymer microneedle patches for influenza vaccination. Nat Med 2010;16:915-20. [PMID: 20639891 DOI: 10.1038/nm.2182] [Cited by in Crossref: 548] [Cited by in F6Publishing: 482] [Article Influence: 45.7] [Reference Citation Analysis]
176 Heurtault B, Frisch B, Pons F. Liposomes as delivery systems for nasal vaccination: strategies and outcomes. Expert Opin Drug Deliv 2010;7:829-44. [PMID: 20459361 DOI: 10.1517/17425247.2010.488687] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 3.2] [Reference Citation Analysis]
177 de Boer AH, Hagedoorn P. The role of disposable inhalers in pulmonary drug delivery. Expert Opinion on Drug Delivery 2014;12:143-57. [DOI: 10.1517/17425247.2014.952626] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
178 Liu Y. Utilization of the venturi effect to introduce micro-particles for epidermal vaccination. Medical Engineering & Physics 2007;29:390-7. [DOI: 10.1016/j.medengphy.2006.05.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
179 Keijzer C, Slütter B, van der Zee R, Jiskoot W, van Eden W, Broere F. PLGA, PLGA-TMC and TMC-TPP nanoparticles differentially modulate the outcome of nasal vaccination by inducing tolerance or enhancing humoral immunity. PLoS One 2011;6:e26684. [PMID: 22073184 DOI: 10.1371/journal.pone.0026684] [Cited by in Crossref: 53] [Cited by in F6Publishing: 58] [Article Influence: 4.8] [Reference Citation Analysis]
180 Kong WH, Sung DK, Kim H, Yang J, Ieronimakis N, Kim KS, Lee J, Kim D, Yun SH, Hahn SK. Self-adjuvanted hyaluronate – antigenic peptide conjugate for transdermal treatment of muscular dystrophy. Biomaterials 2016;81:93-103. [DOI: 10.1016/j.biomaterials.2015.12.007] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
181 Baudner BC, O’hagan DT. Bioadhesive delivery systems for mucosal vaccine delivery. Journal of Drug Targeting 2010;18:752-70. [DOI: 10.3109/1061186x.2010.529143] [Cited by in Crossref: 19] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
182 Hill AB, Kilgore C, Mcglynn M, Jones CH. Improving global vaccine accessibility. Current Opinion in Biotechnology 2016;42:67-73. [DOI: 10.1016/j.copbio.2016.03.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
183 Kastenmuller W, Gasteiger G, Stross L, Busch DH, Drexler I. Cutting edge: mucosal application of a lyophilized viral vector vaccine confers systemic and protective immunity toward intracellular pathogens. J Immunol 2009;182:2573-7. [PMID: 19234150 DOI: 10.4049/jimmunol.0803871] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
184 van den Berg JH, Nujien B, Beijnen JH, Vincent A, van Tinteren H, Kluge J, Woerdeman LA, Hennink WE, Storm G, Schumacher TN, Haanen JB. Optimization of intradermal vaccination by DNA tattooing in human skin. Hum Gene Ther 2009;20:181-9. [PMID: 19301471 DOI: 10.1089/hgt.2008.073] [Cited by in Crossref: 2] [Cited by in F6Publishing: 17] [Article Influence: 0.2] [Reference Citation Analysis]
185 Yagnik B, Sharma D, Padh H, Desai P. Oral immunization with LacVax® OmpA induces protective immune response against Shigella flexneri 2a ATCC 12022 in a murine model. Vaccine 2019;37:3097-105. [PMID: 31047673 DOI: 10.1016/j.vaccine.2019.04.053] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
186 Scheiblhofer S, Thalhamer J, Weiss R. Laser microporation of the skin: prospects for painless application of protective and therapeutic vaccines. Expert Opin Drug Deliv 2013;10:761-73. [PMID: 23425032 DOI: 10.1517/17425247.2013.773970] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
187 Tomar J, Born PA, Frijlink HW, Hinrichs WLJ. Dry influenza vaccines: towards a stable, effective and convenient alternative to conventional parenteral influenza vaccination. Expert Review of Vaccines 2016;15:1431-47. [DOI: 10.1080/14760584.2016.1182869] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
188 Chen F, Yan Q, Yu Y, Wu MX. BCG vaccine powder-laden and dissolvable microneedle arrays for lesion-free vaccination. J Control Release 2017;255:36-44. [PMID: 28390901 DOI: 10.1016/j.jconrel.2017.03.397] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 7.4] [Reference Citation Analysis]
189 Dean HJ. Alternative routes of influenza vaccine delivery. Expert Opin Drug Deliv 2006;3:557-61. [PMID: 16948552 DOI: 10.1517/17425247.3.5.557] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
190 Sun Y, Wang J, Li H, Sun X, Su X, Ma J. Comparison of glucose variability in patients with type 2 diabetes administrated glargine with needle-free jet injector and conventional insulin pen. Expert Opin Drug Deliv 2020;17:713-7. [PMID: 32141347 DOI: 10.1080/17425247.2020.1738381] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
191 Weissmueller NT, Schiffter HA, Pollard AJ. Intradermal powder immunization with protein-containing vaccines. Expert Rev Vaccines 2013;12:687-702. [PMID: 23750797 DOI: 10.1586/erv.13.48] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
192 Deng Y, Mathaes R, Winter G, Engert J. Encapsulation of antigen-loaded silica nanoparticles into microparticles for intradermal powder injection. European Journal of Pharmaceutical Sciences 2014;63:154-66. [DOI: 10.1016/j.ejps.2014.07.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
193 Gratieri T, Alberti I, Lapteva M, Kalia YN. Next generation intra- and transdermal therapeutic systems: using non- and minimally-invasive technologies to increase drug delivery into and across the skin. Eur J Pharm Sci. 2013;50:609-622. [PMID: 23567467 DOI: 10.1016/j.ejps.2013.03.019] [Cited by in Crossref: 72] [Cited by in F6Publishing: 50] [Article Influence: 8.0] [Reference Citation Analysis]
194 Yagnik B, Sharma D, Padh H, Desai P. In vivo delivery of pPERDBY to BALB/c mice by LacVax® DNA-I and comparison of elicited immune response with conventional immunization methods. Gene Ther 2018;25:485-96. [PMID: 30108273 DOI: 10.1038/s41434-018-0033-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
195 Subburaj J, Datey A, Gopalan J, Chakravortty D. Insights into the mechanism of a novel shockwave-assisted needle-free drug delivery device driven by in situ-generated oxyhydrogen mixture which provides efficient protection against mycobacterial infections. J Biol Eng 2017;11:48. [PMID: 29255479 DOI: 10.1186/s13036-017-0088-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
196 Fernando GJ, Chen X, Prow TW, Crichton ML, Fairmaid EJ, Roberts MS, Frazer IH, Brown LE, Kendall MA. Potent immunity to low doses of influenza vaccine by probabilistic guided micro-targeted skin delivery in a mouse model. PLoS One 2010;5:e10266. [PMID: 20422002 DOI: 10.1371/journal.pone.0010266] [Cited by in Crossref: 129] [Cited by in F6Publishing: 120] [Article Influence: 10.8] [Reference Citation Analysis]
197 Frandoloso R, Chaudhuri S, Frandoloso GCP, Yu RH, Schryvers AB. Proof of Concept for Prevention of Natural Colonization by Oral Needle-Free Administration of a Microparticle Vaccine. Front Immunol 2020;11:595320. [PMID: 33193449 DOI: 10.3389/fimmu.2020.595320] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
198 Tandel H, Florence K, Misra A. Protein and Peptide Delivery through Respiratory Pathway. Challenges in Delivery of Therapeutic Genomics and Proteomics. Elsevier; 2011. pp. 429-79. [DOI: 10.1016/b978-0-12-384964-9.00009-8] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
199 Deng Y, Winter G, Myschik J. Preparation and validation of a skin model for the evaluation of intradermal powder injection devices. European Journal of Pharmaceutics and Biopharmaceutics 2012;81:360-8. [DOI: 10.1016/j.ejpb.2012.03.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
200 Gupta A, Eral HB, Hatton TA, Doyle PS. Nanoemulsions: formation, properties and applications. Soft Matter 2016;12:2826-41. [DOI: 10.1039/c5sm02958a] [Cited by in Crossref: 491] [Cited by in F6Publishing: 100] [Article Influence: 81.8] [Reference Citation Analysis]
201 Basak S, Kang HJ, Lee SH, Chu KB, Moon EK, Quan FS. Influenza vaccine efficacy induced by orally administered recombinant baculoviruses. PLoS One 2020;15:e0233520. [PMID: 32459823 DOI: 10.1371/journal.pone.0233520] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
202 Negri DR, Riccomi A, Pinto D, Vendetti S, Rossi A, Cicconi R, Ruggiero P, Del Giudice G, Magistris MTD. Persistence of mucosal and systemic immune responses following sublingual immunization. Vaccine 2010;28:4175-80. [DOI: 10.1016/j.vaccine.2010.04.013] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
203 Zakrewsky M, Kumar S, Mitragotri S. Nucleic acid delivery into skin for the treatment of skin disease: Proofs-of-concept, potential impact, and remaining challenges. J Control Release 2015;219:445-56. [PMID: 26385169 DOI: 10.1016/j.jconrel.2015.09.017] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 6.4] [Reference Citation Analysis]
204 Choi A, Gultepe E, Gracias DH. Pneumatic delivery of untethered microgrippers for minimally invasive biopsy. IEEE Int Conf Control Autom 2017;2017:857-60. [PMID: 31456871 DOI: 10.1109/ICCA.2017.8003172] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
205 Kitaoka M, Naritomi A, Kawabe Y, Kamihira M, Kamiya N, Goto M. Transcutaneous pollinosis immunotherapy using a solid-in-oil nanodispersion system carrying T cell epitope peptide and R848. Bioeng Transl Med 2017;2:102-8. [PMID: 29313026 DOI: 10.1002/btm2.10048] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
206 Trimzi MA, Ham YB. A Needle-Free Jet Injection System for Controlled Release and Repeated Biopharmaceutical Delivery. Pharmaceutics 2021;13:1770. [PMID: 34834185 DOI: 10.3390/pharmaceutics13111770] [Reference Citation Analysis]
207 Olivera N, Castuma CE, Hozbor D, Gaillard ME, Rumbo M, Gómez RM. Immunization with the recombinant Cholera toxin B fused to Fimbria 2 protein protects against Bordetella pertussis infection. Biomed Res Int 2014;2014:421486. [PMID: 24982881 DOI: 10.1155/2014/421486] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
208 Ravichandran E, Al-Saleem FH, Ancharski DM, Elias MD, Singh AK, Shamim M, Gong Y, Simpson LL. Trivalent vaccine against botulinum toxin serotypes A, B, and E that can be administered by the mucosal route. Infect Immun 2007;75:3043-54. [PMID: 17371853 DOI: 10.1128/IAI.01893-06] [Cited by in Crossref: 73] [Cited by in F6Publishing: 34] [Article Influence: 4.9] [Reference Citation Analysis]
209 Price DN, Kunda NK, Mcbride AA, Muttil P. Vaccine Preparation. In: Hickey AJ, Misra A, Fourie PB, editors. Drug Delivery Systems for Tuberculosis Prevention and Treatment. Chichester: John Wiley & Sons, Ltd; 2016. pp. 67-90. [DOI: 10.1002/9781118943182.ch4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
210 Vyas SP, Gupta PN. Implication of nanoparticles/microparticles in mucosal vaccine delivery. Expert Review of Vaccines 2014;6:401-18. [DOI: 10.1586/14760584.6.3.401] [Cited by in Crossref: 60] [Cited by in F6Publishing: 53] [Article Influence: 7.5] [Reference Citation Analysis]
211 Pan CH, Nair N, Adams RJ, Zink MC, Lee EY, Polack FP, Singh M, O'Hagan DT, Griffin DE. Dose-dependent protection against or exacerbation of disease by a polylactide glycolide microparticle-adsorbed, alphavirus-based measles virus DNA vaccine in rhesus macaques. Clin Vaccine Immunol 2008;15:697-706. [PMID: 18287579 DOI: 10.1128/CVI.00045-08] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
212 Kwon KM, Lim SM, Choi S, Kim DH, Jin HE, Jee G, Hong KJ, Kim JY. Microneedles: quick and easy delivery methods of vaccines. Clin Exp Vaccine Res 2017;6:156-9. [PMID: 28775980 DOI: 10.7774/cevr.2017.6.2.156] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
213 Senti G, von Moos S, Kündig TM. Epicutaneous Immunotherapy for Aeroallergen and Food Allergy. Curr Treat Options Allergy 2014;1:68-78. [PMID: 24918342 DOI: 10.1007/s40521-013-0003-8] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 3.2] [Reference Citation Analysis]
214 Pai Kasturi S, Qin H, Thomson KS, El-Bereir S, Cha SC, Neelapu S, Kwak LW, Roy K. Prophylactic anti-tumor effects in a B cell lymphoma model with DNA vaccines delivered on polyethylenimine (PEI) functionalized PLGA microparticles. J Control Release 2006;113:261-70. [PMID: 16793161 DOI: 10.1016/j.jconrel.2006.04.006] [Cited by in Crossref: 66] [Cited by in F6Publishing: 61] [Article Influence: 4.1] [Reference Citation Analysis]
215 Srivastava G, Walke S, Dhavale D, Gade W, Doshi J, Kumar R, Ravetkar S, Doshi P. Tartrate/tripolyphosphate as co-crosslinker for water soluble chitosan used in protein antigens encapsulation. Int J Biol Macromol 2016;91:381-93. [PMID: 27246374 DOI: 10.1016/j.ijbiomac.2016.05.099] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
216 Johansen P, von Moos S, Mohanan D, Kündig TM, Senti G. New routes for allergen immunotherapy. Hum Vaccin Immunother. 2012;8:1525-1533. [PMID: 23095873 DOI: 10.4161/hv.21948] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
217 Serr I, Weigmann B, Franke RK, Daniel C. Treg vaccination in autoimmune type 1 diabetes. BioDrugs 2014;28:7-16. [PMID: 23959795 DOI: 10.1007/s40259-013-0060-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
218 Zeng D, Wu N, Xie L, Xia X, Kang Y. An experimental study of a spring-loaded needle-free injector: Influence of the ejection volume and injector orifice diameter. J Mech Sci Technol 2019;33:5581-8. [DOI: 10.1007/s12206-019-1051-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
219 Koutsonanos DG, del Pilar Martin M, Zarnitsyn VG, Sullivan SP, Compans RW, Prausnitz MR, Skountzou I. Transdermal influenza immunization with vaccine-coated microneedle arrays. PLoS One 2009;4:e4773. [PMID: 19274084 DOI: 10.1371/journal.pone.0004773] [Cited by in Crossref: 131] [Cited by in F6Publishing: 121] [Article Influence: 10.1] [Reference Citation Analysis]
220 Wack A, Seubert A, Hilleringmann M. [Novel vaccines. Vaccinations in the near and distant future]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2009;52:1083-90. [PMID: 19760246 DOI: 10.1007/s00103-009-0953-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
221 Nakayama H, Portaro R, Kiyanda CB, Ng HD. CFD MODELING OF HIGH SPEED LIQUID JETS FROM AN AIR-POWERED NEEDLE-FREE INJECTION SYSTEM. J Mech Med Biol 2016;16:1650045. [DOI: 10.1142/s0219519416500457] [Cited by in Crossref: 9] [Article Influence: 1.5] [Reference Citation Analysis]
222 Lee G, Na YJ, Yang B, Choi J, Seo YB, Hong C, Yun CH, Kim DH, Sohn EJ, Kim JH, Sung YC, Kim Y, Jang MH, Hwang I. Oral immunization of haemaggulutinin H5 expressed in plant endoplasmic reticulum with adjuvant saponin protects mice against highly pathogenic avian influenza A virus infection. Plant Biotechnol J 2015;13:62-72. [DOI: 10.1111/pbi.12235] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
223 Stachowiak JC, von Muhlen MG, Li TH, Jalilian L, Parekh SH, Fletcher DA. Piezoelectric control of needle-free transdermal drug delivery. Journal of Controlled Release 2007;124:88-97. [DOI: 10.1016/j.jconrel.2007.08.017] [Cited by in Crossref: 62] [Cited by in F6Publishing: 40] [Article Influence: 4.1] [Reference Citation Analysis]
224 Skountzou I, Kang S. Transcutaneous Immunization with Influenza Vaccines. In: Compans RW, Orenstein WA, editors. Vaccines for Pandemic Influenza. Berlin: Springer Berlin Heidelberg; 2009. pp. 347-68. [DOI: 10.1007/978-3-540-92165-3_17] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
225 Arora A, Hakim I, Baxter J, Rathnasingham R, Srinivasan R, Fletcher DA, Mitragotri S. Needle-free delivery of macromolecules across the skin by nanoliter-volume pulsed microjets. Proc Natl Acad Sci U S A 2007;104:4255-60. [PMID: 17360511 DOI: 10.1073/pnas.0700182104] [Cited by in Crossref: 101] [Cited by in F6Publishing: 70] [Article Influence: 6.7] [Reference Citation Analysis]
226 Tanizaki H, Nakashima C, Shimizuhira C, Miyachi Y, Kabashima K. Performance comparison of a novel intradermal injection system with the Mantoux technique. J Dermatol Sci 2015;79:310-3. [PMID: 26187265 DOI: 10.1016/j.jdermsci.2015.06.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
227 Rivera-Patron M, Moreno M, Baz M, Roehe PM, Cibulski SP, Silveira F. ISCOM-like Nanoparticles Formulated with Quillaja brasiliensis Saponins Are Promising Adjuvants for Seasonal Influenza Vaccines. Vaccines (Basel) 2021;9:1350. [PMID: 34835281 DOI: 10.3390/vaccines9111350] [Reference Citation Analysis]
228 Ogura M, Paliwal S, Mitragotri S. Low-frequency sonophoresis: current status and future prospects. Adv Drug Deliv Rev 2008;60:1218-23. [PMID: 18450318 DOI: 10.1016/j.addr.2008.03.006] [Cited by in Crossref: 110] [Cited by in F6Publishing: 89] [Article Influence: 7.9] [Reference Citation Analysis]
229 Licciardi PV, Underwood JR. Identification of a novel vaccine adjuvant that stimulates and maintains diphtheria toxoid immunity. Vaccine 2010;28:3865-73. [DOI: 10.1016/j.vaccine.2010.02.073] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
230 Liard C, Munier S, Arias M, Joulin-giet A, Bonduelle O, Duffy D, Shattock RJ, Verrier B, Combadière B. Targeting of HIV-p24 particle-based vaccine into differential skin layers induces distinct arms of the immune responses. Vaccine 2011;29:6379-91. [DOI: 10.1016/j.vaccine.2011.04.080] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 4.1] [Reference Citation Analysis]
231 Nauman EB, Patel K, Karande P. Design of optimized diffusion-controlled transdermal drug delivery systems. Drug Development and Industrial Pharmacy 2010;37:93-102. [DOI: 10.3109/03639045.2010.495751] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
232 Vij M, Alam S, Gupta N, Gotherwal V, Gautam H, Ansari KM, Santhiya D, Natarajan VT, Ganguli M. Non-invasive Oil-Based Method to Increase Topical Delivery of Nucleic Acids to Skin. Mol Ther 2017;25:1342-52. [PMID: 28366765 DOI: 10.1016/j.ymthe.2017.03.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
233 Kong Q, Higasijima K, Wakabayashi R, Tahara Y, Kitaoka M, Obayashi H, Hou Y, Kamiya N, Goto M. Transcutaneous Delivery of Immunomodulating Pollen Extract-Galactomannan Conjugate by Solid-in-Oil Nanodispersions for Pollinosis Immunotherapy. Pharmaceutics 2019;11:E563. [PMID: 31671640 DOI: 10.3390/pharmaceutics11110563] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
234 Alkilani AZ, McCrudden MT, Donnelly RF. Transdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the stratum corneum. Pharmaceutics 2015;7:438-70. [PMID: 26506371 DOI: 10.3390/pharmaceutics7040438] [Cited by in Crossref: 267] [Cited by in F6Publishing: 205] [Article Influence: 38.1] [Reference Citation Analysis]
235 Schulze K, Ebensen T, Riese P, Prochnow B, Lehr CM, Guzmán CA. New Horizons in the Development of Novel Needle-Free Immunization Strategies to Increase Vaccination Efficacy. Curr Top Microbiol Immunol 2016;398:207-34. [PMID: 27370343 DOI: 10.1007/82_2016_495] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
236 Kim YC, Prausnitz MR. Enabling skin vaccination using new delivery technologies. Drug Deliv Transl Res 2011;1:7-12. [PMID: 21799951 DOI: 10.1007/s13346-010-0005-z] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 7.3] [Reference Citation Analysis]
237 Kitaoka M, Imamura K, Hirakawa Y, Tahara Y, Kamiya N, Goto M. Sucrose laurate-enhanced transcutaneous immunization with a solid-in-oil nanodispersion. Med Chem Commun 2014;5:20-4. [DOI: 10.1039/c3md00164d] [Cited by in Crossref: 22] [Article Influence: 2.8] [Reference Citation Analysis]
238 Gregory JA, Topol AB, Doerner DZ, Mayfield S. Alga-produced cholera toxin-Pfs25 fusion proteins as oral vaccines. Appl Environ Microbiol 2013;79:3917-25. [PMID: 23603678 DOI: 10.1128/AEM.00714-13] [Cited by in Crossref: 73] [Cited by in F6Publishing: 28] [Article Influence: 8.1] [Reference Citation Analysis]
239 Amorij JP, Huckriede A, Wilschut J, Frijlink HW, Hinrichs WL. Development of stable influenza vaccine powder formulations: challenges and possibilities. Pharm Res 2008;25:1256-73. [PMID: 18338241 DOI: 10.1007/s11095-008-9559-6] [Cited by in Crossref: 135] [Cited by in F6Publishing: 121] [Article Influence: 9.6] [Reference Citation Analysis]
240 Otsu K, Fleischer DM. Therapeutics in food allergy: the current state of the art. Curr Allergy Asthma Rep 2012;12:48-54. [PMID: 22101989 DOI: 10.1007/s11882-011-0235-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
241 Chen X, Prow TW, Crichton ML, Jenkins DW, Roberts MS, Frazer IH, Fernando GJ, Kendall MA. Dry-coated microprojection array patches for targeted delivery of immunotherapeutics to the skin. Journal of Controlled Release 2009;139:212-20. [DOI: 10.1016/j.jconrel.2009.06.029] [Cited by in Crossref: 132] [Cited by in F6Publishing: 115] [Article Influence: 10.2] [Reference Citation Analysis]
242 van den Berg JH, Nuijen B, Schumacher TN, Haanen JB, Storm G, Beijnen JH, Hennink WE. Synthetic vehicles for DNA vaccination. J Drug Target 2010;18:1-14. [PMID: 19814658 DOI: 10.3109/10611860903278023] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
243 Saitoh A, Aizawa Y, Sato I, Hirano H, Sakai T, Mori M. Skin thickness in young infants and adolescents: Applications for intradermal vaccination. Vaccine 2015;33:3384-91. [DOI: 10.1016/j.vaccine.2015.04.081] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]